Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats
about
Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic EffectsResveratrol and Ophthalmic DiseasesRole of Natural Stilbenes in the Prevention of CancerAn Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of ResveratrolPolyphenol Stilbenes: Molecular Mechanisms of Defence against Oxidative Stress and Aging-Related DiseasesPolyphenols and the human brain: plant “secondary metabolite” ecologic roles and endogenous signaling functions drive benefitsA review of pterostilbene antioxidant activity and disease modificationIdebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout miceResveratrol acts not through anti-aggregative pathways but mainly via its scavenging properties against Aβ and Aβ-metal complexes toxicityPterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancerIdentification of resveratrol oligomers as inhibitors of cystic fibrosis transmembrane conductance regulator by high-throughput screening of natural products from chinese medicinal plantsAnticancer activities of pterostilbene-isothiocyanate conjugate in breast cancer cells: involvement of PPARγPterostilbene-isothiocyanate conjugate suppresses growth of prostate cancer cells irrespective of androgen receptor statusPterostilbene simultaneously induced G0/G1-phase arrest and MAPK-mediated mitochondrial-derived apoptosis in human acute myeloid leukemia cell linesStabilization of resveratrol in blood circulation by conjugation to mPEG and mPEG-PLA polymers: investigation of conjugate linker and polymer composition on stability, metabolism, antioxidant activity and pharmacokinetic profileCase-specific potentiation of glioblastoma drugs by pterostilbeneResveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathwaysIn vitro and in vivo activities of pterostilbene against Candida albicans biofilms.Pterostilbene, a Methoxylated Resveratrol Derivative, Efficiently Eradicates Planktonic, Biofilm, and Intracellular MRSA by Topical Application.Anticancer Activity of Pterostilbene in Human Ovarian Cancer Cell LinesPterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial.Biosynthesis of methylated resveratrol analogs through the construction of an artificial biosynthetic pathway in E. coli.Calorie restriction combined with resveratrol induces autophagy and protects 26-month-old rat hearts from doxorubicin-induced toxicityFatty acid synthase methylation levels in adipose tissue: effects of an obesogenic diet and phenol compounds.Genomic analysis of pterostilbene predicts its antiproliferative effects against pancreatic cancer in vitro and in vivoResveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomasResveratrol analogs: promising chemopreventive agents.Grape polyphenols inhibit Akt/mammalian target of rapamycin signaling and potentiate the effects of gefitinib in breast cancer.Resveratrol derivatives: a patent review (2009 - 2012).Resveratrol metabolism in a non-human primate, the grey mouse lemur (Microcebus murinus), using ultra-high-performance liquid chromatography-quadrupole time of flightNew multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol.Inhibitory effects of resveratrol and pterostilbene on human colon cancer cells: a side-by-side comparisonPterostilbene attenuates inflammation in rat heart subjected to ischemia-reperfusion: role of TLR4/NF-κB signaling pathwayDetermination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs.Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1.Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differencesAnalytical method development for synthesized conjugated metabolites of trans-resveratrol, and application to pharmacokinetic studies.Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activityResveratrol Antagonizes Antimicrobial Lethality and Stimulates Recovery of Bacterial Mutants.In vivo-formed versus preformed metabolite kinetics of trans-resveratrol-3-sulfate and trans-resveratrol-3-glucuronide.
P2860
Q26741423-10B9D102-6259-45F3-85CB-73EAACFDEA6EQ26750615-E712F80A-B173-408E-8B5A-1669806ED22AQ26769976-98EDA5BC-4B50-47CE-8A5D-C65B195A7EFCQ26800907-9B466E47-8464-4E42-88E0-C9A9126A35DCQ26800956-62E048A7-28F4-4082-8176-384E522F653BQ26992098-0B78C8FF-B55F-4C93-A9C1-963BE46E84B8Q28291048-716FBD3D-80EE-489F-A928-5C8AF0E0C51BQ28478469-11EECA26-7488-43E1-BE3C-FEAC957D8408Q28478772-2CB4823C-7716-4159-83F8-1F8F15250250Q28487488-C971C7F7-86FB-403E-9DF9-79B8E6283270Q28537590-B250AE83-0BE5-44CD-91A1-65956BD8B8FBQ28541836-D5BCF34A-0A2A-4E54-89A7-A326332CE04EQ28541923-02590A0B-FE33-48BC-B66D-33EE870E8DEFQ28542481-70021A8E-834A-42F2-821C-D3B91ABBF2EDQ28544851-50D7ECC1-AB5C-4DEA-AF9A-E304B1E6CFCAQ29048651-45C9FD71-B1CF-4119-901B-E6BE8D3461F0Q30538924-4F941666-E141-4693-B975-173BB20EAB1AQ33622833-C07EF82F-3B4B-4AAE-9624-6F4537916A67Q33790112-FD477A99-7202-410E-9A31-3F08298683C7Q33888129-688ACBCE-9FEF-4551-AAFA-2FC2F18909E1Q33905661-6AAB887B-C88C-47D0-B5B4-E701DAE2BB7BQ33987762-0CAB51FB-18F0-4827-BFE7-15F545695F46Q34098331-E6F65FC3-BA9C-4A5B-AFE4-15A664CB146CQ34212884-448C0717-A161-4A97-8661-34598D75CCCFQ34541180-75F23D35-87E6-45E5-997C-03917592AAFFQ34786554-C4620205-56F7-4067-9768-1F6038BA91B9Q34820199-BDC2CCF2-2B96-4DC0-8D1D-E4170BBD0A2BQ34855692-E219F35C-22CB-4132-95F6-737AFCAF377CQ34986494-C45827A5-2202-469F-88F7-4542A16C2084Q35129419-EF2463E0-04E2-4E20-BF28-F75EF8A65A63Q35199867-FC9A46BB-511D-4D0B-B3BF-A4F1820D2E9BQ35445753-6B02D1A5-5051-4656-B895-EAABF91C3300Q35479336-E0CEE0AD-CC9E-463F-B368-603433D9367FQ35607205-DAD53B08-0632-42B9-90E5-7970A9A22FC4Q35747309-43B10A1F-3D1A-4B41-BEED-8E30A3F088BEQ35805586-216E6601-F60E-42A5-9569-228A79E9263EQ35823165-E51D811E-927A-4546-9001-06D0D4283853Q35832689-712AA4FA-C921-4E41-A6DB-5DAFCB12E72AQ35979673-5BAFDFEB-C32D-4102-9E12-804E8DAEB094Q36296199-BD86C7C4-25A8-498F-8E79-53D0F773B6B8
P2860
Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pharmacokinetics, oral bioavai ...... analog, pterostilbene, in rats
@ast
Pharmacokinetics, oral bioavai ...... analog, pterostilbene, in rats
@en
Pharmacokinetics, oral bioavai ...... analog, pterostilbene, in rats
@nl
type
label
Pharmacokinetics, oral bioavai ...... analog, pterostilbene, in rats
@ast
Pharmacokinetics, oral bioavai ...... analog, pterostilbene, in rats
@en
Pharmacokinetics, oral bioavai ...... analog, pterostilbene, in rats
@nl
prefLabel
Pharmacokinetics, oral bioavai ...... analog, pterostilbene, in rats
@ast
Pharmacokinetics, oral bioavai ...... analog, pterostilbene, in rats
@en
Pharmacokinetics, oral bioavai ...... analog, pterostilbene, in rats
@nl
P2093
P2860
P3181
P1476
Pharmacokinetics, oral bioavai ...... analog, pterostilbene, in rats
@en
P2093
David L McCormick
Izet M Kapetanovic
Miguel Muzzio
Thomas N Thompson
Zhihua Huang
P2860
P2888
P304
P3181
P356
10.1007/S00280-010-1525-4
P407
P577
2011-09-01T00:00:00Z
P5875
P6179
1031864064